3 results
Primary Objectives* Phase 1b lead-in: To assess safety and tolerability of a single dose level of avelumab in combination withincreasing dose levels of other immune modulators in combination with a single doselevel of avelumab in patients with…
Primary objectiveThe objective of this study is to demonstrate the 12 month stability of cTnT in native serum, Li-heparin plasma and K2-EDTA plasma samples at -20 ± 5 °C, > 4 hours at 15 to 25 °C, > 24 hours at 2 to 8°C and > 12…
This is a phase I study of hydroxyurea and dose-intense temozolomide in patients with recurrent glioblastoma that are elegise for re-challenge temozolomide.Primary Objective: To determine the maximal tolerated dose and safety profile of daily…